Gangstem Biotech, Patent on Method for Manufacturing Induced Neural Stem Cells
[Asia Economy Reporter Oh Ju-yeon] Kangstem Biotech announced on the 14th that it has obtained a domestic patent for a method of producing neural stem cells induced from non-neural cells through direct programming and its applications. The company stated, "By precisely controlling the amount of virus containing Sox2 and c-Myc, neural stem cells can be produced solely by the introduction of Sox2 and c-Myc, and the genetic stability and differentiation ability of the produced induced neural stem cells can be confirmed."
Hot Picks Today
"Why Live in Seoul When You Can Pay Half Here?" 30 Minutes to Gangnam... Private Sales Begin in Gyeyang New Town
- "Living Becomes Easier Thanks to SK Hynix, But Conservative U.S. Cities Remain Torn Inside [U.S. Midterm Election D-40]②-2"
- "I Went for the Cheap Coffee, but Now I Feel Uneasy"... Major Coffee Franchises Cited for Violations One After Another
- "Had All My Tickets Booked for Chuseok"... Measles Outbreak and Typhoon Cause Chaos, but Japan Remains Top Choice
- "After Spending 170,000 Won on Hanwoo, This Is What I Got": Why Webtoon Artist Kim Gyusam Decided to Give Cash Instead
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
